Zoetis Inc. (NYSE:ZTS) Plans Quarterly Dividend of $0.53

Key Points

• Zoetis declared a quarterly dividend of $0.53 per share, payable December 1 to shareholders of record on October 30. The annualized dividend is $2.12 per share, representing a 2.9% yield.
• The company has increased its dividend for 14 consecutive years, with a current payout ratio of 31%, indicating the dividend is well covered by earnings. Analysts expect a future payout ratio of approximately 33.5%.
• Zoetis reported quarterly earnings of $1.87 per share, exceeding estimates of $1.85, while revenue declined 0.2% year over year to $2.47 billion. Management’s fiscal 2026 EPS guidance is $6.15–$6.25.

Zoetis Inc. (NYSE:ZTS - Get Free Report) announced a quarterly dividend on Thursday, October 8th. Stockholders of record on Friday, October 30th will be paid a dividend of $0.53 per share on Tuesday, December 1st. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Friday, October 30th.

Zoetis has increased its dividend by an average of 0.2%annually over the last three years and has raised its dividend every year for the last 14 years. Zoetis has a dividend payout ratio of 31.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Zoetis to earn $6.33 per share next year, which means the company should continue to be able to cover its $2.12 annual dividend with an expected future payout ratio of 33.5%.

Zoetis Trading Up 2.1%

NYSE ZTS opened at $73.08 on Friday. Zoetis has a one year low of $68.77 and a one year high of $148.30. The company's 50 day moving average price is $73.97 and its 200 day moving average price is $84.93. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.84 and a current ratio of 3.08. The firm has a market capitalization of $30.20 billion, a price-to-earnings ratio of 12.04, a PEG ratio of 1.67 and a beta of 0.74.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $1.87 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.02. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The firm had revenue of $2.47 billion for the quarter, compared to analysts' expectations of $2.50 billion. During the same period in the previous year, the company posted $1.76 earnings per share. Zoetis's revenue was down .2% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, sell-side analysts predict that Zoetis will post 6.2 EPS for the current year.

About Zoetis

Zoetis Inc is a global animal health company that develops, manufactures and commercializes medicines, vaccines, diagnostics and other products for pets and livestock. Its portfolio is designed to help prevent and treat disease, improve animal health and support veterinary care.

The company serves the companion animal market with products for dogs, cats and other pets, including parasiticides, vaccines, dermatology treatments and pain-management therapies. Zoetis also provides animal health products for cattle, swine, poultry, fish and other livestock, along with diagnostic instruments, tests and services used by veterinarians and producers.

Zoetis was established as an independent public company in 2013 after being separated from Pfizer, which had operated the business as Pfizer Animal Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.